Marie-Claire Peakman
InvestorExecutive Director, WWBD / Partner at Pfizer Venture Investments
Singapore
Find your path to Marie-Claire
133 people in our graph share verified history with Marie-Claire — schools, employers, funds. One of them is your warm intro.
Jay ParrishunlockedMarie-Claire: together at Vaccine Company (2025–2026)
×2Marie-Claire: together at University of Nottingham
Marie-Claire: together at DEM Biopharma, Inc.
×5Marie-Claire: together at Yale School of Medicine
About
Marie-Claire Peakman is a Partner at Pfizer Ventures, where she invests in early-stage private biotechnology companies, and an Executive Director in Pfizer's Worldwide Business Development and Research & Development. She holds a B.Pharm.Hons. in Pharmacy and a Ph.D. in Physiology and Pharmacology from the University of Nottingham, completed postdoctoral work at Yale University, and has spent 26 years at Pfizer, including founding the Primary Pharmacology Group in 2009 and leading it for 12 years, during which it identified compounds including nirmatrelvir (Paxlovid), abrocitinib (Cibinqo), and ritlecitinib (Litfulo). She serves as Immediate Past Chair of the Board of Directors for the United Way of Southeastern Connecticut and Vice Chair on the Boards of Trustees for Lawr
Experience
- PfizerPartner, Pfizer Ventures || Executive Director, Pfizer Research & Developmentcurrent2021 — presentGroton, Connecticut, United States
- PfizerExecutive Director, Medicine Design2011 — 2021Groton CT
- PfizerExecutive Director, Head of Groton and Sandwich Research Centers of Emphasis2009 — 2011
- PfizerSenior Director, Cardiovascular, Metabolic & Endocrine Diseases2007 — 2009
- PfizerSenior Principal Scientist, Lead Generation Group2005 — 2007
- PfizerSenior Principal Scientist, New Leads Biology2003 — 2005
- PfizerSenior Research Scientist, New Leads Biology1999 — 2003
- Mediar TherapeuticsMember Board of Directorscurrent2025 — present
- Vaccine CompanyMember Board of Directorscurrent2025 — present
- TRIMTECH Therapeutics LimitedMember Board of Directorscurrent2025 — present
- NormunityMember Board of Directorscurrent2025 — present
- Curve TherapeuticsMember Board of Directorscurrent2024 — presentSouthampton, England, United Kingdom
- Mozart Therapeutics, IncMember Board of Directorscurrent2023 — presentSeattle, Washington, United States
- Grey Wolf TherapeuticsMember Board of Directorscurrent2022 — present
- DEM Biopharma, Inc.Member Board of Directorscurrent2022 — present
- The Wellcome FoundationProduct Development Labs1990 — 1991
Skills & more
Pharmacology71Drug Discovery65Microscopy3Drug Development22In Vitro8Assay Development31High Throughput Screening35Oncology6Infectious Diseases1Cell19DNA8Pharmacokinetics13
+10 more
Cell BiologyNeuroscienceRegulatory AffairsADMEMetabolismBiomarker DiscoveryLaboratoryClinical DevelopmentTeam LeadershipPharmaceutical Industry- Boards That Lead: Corporate Governance That Builds Value — Wharton Executive Education
- Leadership Development Program — Eckerd College
- VC University ONLINE — VC University
From Marie-Claire's professional profile.
Colleagues at Pfizer Venture Investments
Ama Amoah
Finance Director, Business Development at Pfizer Venture Investments
Andrew J. Muratore
Vice President & Chief Counsel, M&A and Licensing at Pfizer Venture Investments
Anthony Barry
Executive Director, WWBD / Partner at Pfizer Venture Investments
Artem Smirnov
Partner at Xora
Boyoon Choi
Senior Corporate Counsel at Pfizer Venture Investments
Carlos Murillo
Presidente Pfizer España at Taram Capital
Christopher O'Donnell
Partner at Pfizer Venture Investments
Gillian Akai
Senior Vice President, General Counsel, Communications and Corporate Secretary at Maple Leaf Foods strategic venture activity
Frequently asked questions
- Who is Marie-Claire Peakman?
- Marie-Claire Peakman is a Partner at Pfizer Ventures, where she invests in early-stage private biotechnology companies, and an Executive Director in Pfizer's Worldwide Business Development and Research & Development. She holds a B.Pharm.Hons. in Pharmacy and a Ph.D. in Physiology and Pharmacology from the University of Nottingham, completed postdoctoral work at Yale University, and has spent 26 years at Pfizer, including founding the Primary Pharmacology Group in 2009 and leading it for 12 years, during which it identified compounds including nirmatrelvir (Paxlovid), abrocitinib (Cibinqo), and ritlecitinib (Litfulo). She serves as Immediate Past Chair of the Board of Directors for the United Way of Southeastern Connecticut and Vice Chair on the Boards of Trustees for Lawr
- Where does Marie-Claire Peakman work?
- Marie-Claire Peakman is Executive Director, WWBD / Partner at Pfizer Venture Investments.
- Where did Marie-Claire Peakman go to school?
- Marie-Claire Peakman studied at Yale School of Medicine (Molecular Psychiatry); Yale School of Medicine (Molecular Biophysics & Biochemistry); University of Nottingham (PhD, Physiology and Pharmacology).
Same school
Also attended Yale School of Medicine53
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpElias QuijanoPrincipal at Northpond VenturesJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalAlley (Welsh) OlshanskyAdvisor at Casdin Capital
+ 47 more
Also attended University of Nottingham229
Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersRichard LeeInvestor at MedicxiMillan SuriPrincipal at Episode1Kieran RafterPrincipal at Marlin Equity PartnersTim SchmidtVice President, Fund Finance at Northpond VenturesRohan OzaCo-Founder & Managing Partner at CAVU Consumer Partners
+ 223 more
Also attended Eckerd College12
Sharon RodriguezVenture Partner at 1843 CapitalAlex BodneyCo-Founder, Partner at MidnightJason TronniVice President at Vedanta CapitalOliver WillensVice President at 50 South CapitalRosemary PurringtonAdministrative Manager at LFM Capital, LLCJonathan CordeauGeneral Partner at undefined capital
+ 6 more
Shared employers
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more
Also worked at Mediar Therapeutics10
Adam CottonPrincipal at Novartis Venture FundAnja KoenigGlobal Head of NVF at Novartis Venture FundOliver WalkerManaging Partner at CGS Management AGAnja KönigGlobal Head at Novartis Venture FundChristoph KocherPrincipal at GimvAndreas JurgeitPartner at Gimv
+ 4 more
